October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Sumanta K. Pal: Subanalysis of patients in IMmotion010 with sarcomatoid features
Jul 12, 2024, 14:31

Sumanta K. Pal: Subanalysis of patients in IMmotion010 with sarcomatoid features

Sumanta K. Pal, Kidney Cancer Professor at City of Hope shared an article by Jose Antonio Karam et al., on X:

Title: Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010

Authors: Jose Antonio Karam, Robert Uzzo, Axel Bexe, William Leung, Connie Tat, Alan Nicholas, Alexander Andreev-Drakhlin, Mahrukh Huseni, Sumanta Kumar Pal, Viraj A. Master.

Sumanta K. Pal: Subanalysis of patients in IMmotion010 with sarcomatoid features

“Congrats to Dr. Jose Karam, MD Anderson Cancer Center and Viraj Master, Winship Cancer Institute of Emory University who drove this important subanalysis of patients in IMmotion010 who had sarcomatoid features. No statistically significant difference in DFS – curves shown below. So appreciative of Society of Urologic Oncology members like Jose and Viraj who really drove accrual to this trial.”

Source: Sumanta K. Pal/X

Sumanta (Monty) Pal, MD, is a medical oncologist and an expert in genitourinary cancers at the City of Hope Comprehensive Cancer Center in Los Angeles. He serves as the co-director of the Kidney Cancer Program and leads the Kidney and Bladder Cancer Disease Team at City of Hope. He specialises in kidney, bladder, and prostate cancers.